CL — Colgate-Palmolive Company

Is CL overbought or oversold? Here is the current MarketMoodz read.

Consumer Defensive · Household & Personal Products

Neutral As of October 3, 2026

Colgate-Palmolive Company (CL) currently reads Neutral on the MarketMoodz overbought/oversold meter, as of October 3, 2026. The Consumer Defensive name (Household & Personal Products) last closed at $84.26. The rating moved from Oversold to Neutral on October 2, 2026.

AI analysis

Colgate-Palmolive Company (CL) is a mature, cash-generative consumer staples leader with durable brand franchises and steady global demand for oral- and personal-care products. Financial health is supported by predictable free cash flow, a conservative balance sheet and a strong dividend profile. Near-term catalysts include defensive sector flows, ongoing productivity and pricing initiatives, and potential margin improvement from supply-chain efficiencies. Primary challenges are input-cost dynamics, currency exposure and competitive pressure from private-label and agile challenger brands. Social and SEC sentiment is neutral-to-slightly positive; absent macro shocks the company is positioned to deliver stable cash generation and modest organic growth. Scenarios to monitor include sharper-than-expected cost inflation, regulatory actions on product claims, or accelerated share gains by low-cost competitors that could compress margins.

Key factors

  • Defensive consumer-staples positioning with stable, recession-resilient demand for oral-care and personal-care products
  • Strong global brands (Colgate, Palmolive) and leading market shares in toothpaste and oral hygiene across many markets
  • Consistent free cash flow generation and a long history of returning capital via dividends and buybacks
  • Pricing power supported by brand equity, enabling partial offset of input-cost inflation
  • Operational efficiency initiatives and potential margin tailwinds from supply-chain automation and productivity programs
  • Sector-level investor rotation into value/yield defensive names providing near-term support to shares
  • Limited near-term headline risk in filings (recent SEC items flagged neutral/positive sentiment)

Risks

  • Input-cost inflation (raw materials, freight, energy) and slower pass-through of price increases in competitive markets
  • Foreign-exchange volatility given sizable emerging-market exposure
  • Heightened regulatory scrutiny on labeling, health claims and product safety in consumer-health categories
  • Intensifying competition from private-label and digitally native oral-care brands eroding share or forcing promotional activity
  • Geopolitical or supply-chain disruptions that raise logistics costs or disrupt production
  • Slower discretionary spending in key markets that could pressure volume growth and promotional intensity

Latest MarketMoodz coverage

See today's live rating, score and targets

Members see the live hourly rating for CL — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.